Clinical Trial Update: SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of SNC115 injections for patients with recurrent/refractory small cell lung cancer and large cell neuroendocrine carcinoma of the lung; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large Cell Neuroendocrine Carcinoma of the Lung
• Small Cell Lung Cancer

Drugs mentioned

• SNC115

Snippet

Sponsor: Shanghai Simnova Biotechnology Co.,Ltd. | Conditions: Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma | Phase 1 | Status: RECRUITING